Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: cluster randomised controlled trial

BMJ. 2010 Dec 1:341:c6387. doi: 10.1136/bmj.c6387.

Abstract

Objective: To evaluate the effects of a community based integrated intervention for early prevention and management of chronic obstructive pulmonary disease (COPD) in China.

Design: Cluster randomised controlled trial.

Setting: Eight healthcare units in two communities.

Participants: Of 1062 people aged 40-89, 872 (101 with COPD and 771 without COPD) who fulfilled the inclusion and exclusion criteria were allocated to the intervention or the usual care programmes.

Intervention: Participants randomly assigned to integrated intervention (systematic health education, intensive and individualised intervention, treatment, and rehabilitation) or usual care.

Main outcome measures: Annual rate of decline in forced expiratory rate in one second (FEV(1)) before use of bronchodilator.

Results: Annual rate of decline in FEV(1) was significantly lower in the intervention community than the control community, with an adjusted difference of 19 ml/year (95% confidence interval 3 to 36) and 0.9% (0.1% to 1.8%) of predicted values (all P<0.05), as well as a lower annual rate of decline in FEV(1)/FVC (forced vital capacity) ratio (adjusted difference 0.6% (0.1% to 1.2%) P=0.029). There were also higher rates of smoking cessation (21% v 8%, P<0.004) and lower cumulative death rates from all causes (1% v 3%, P<0.009) in the intervention community than in the control community during the four year follow-up. Improvements in knowledge of COPD and smoking hazards, outdoor air quality, environmental tobacco smoke, and working conditions were also achieved (all P<0.05). The difference in cumulative incidence rate of COPD (both around 4%) and cumulative death rate from COPD (2% v 11%) did not reach significance between the two communities.

Conclusions: A community based integrated intervention can have a significant impact on the prevention and management of COPD, mainly reflected in the annual rate of decline in FEV(1).

Trial registration: Chinese Clinical Trials Registration (ChiCTR-TRC-00000532).

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adult
  • Aged
  • Aged, 80 and over
  • Air Pollutants / analysis
  • Air Pollution / prevention & control
  • Bronchodilator Agents / administration & dosage
  • China
  • Cluster Analysis
  • Community Health Services
  • Early Diagnosis
  • Female
  • Forced Expiratory Volume / physiology
  • Health Education
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Pulmonary Disease, Chronic Obstructive / prevention & control
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Sulfur Dioxide / analysis
  • Surveys and Questionnaires
  • Vital Capacity

Substances

  • Air Pollutants
  • Bronchodilator Agents
  • Sulfur Dioxide